Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.65 USD | -6.69% | -9.25% | -21.60% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 329K | Capitalization | 99.6M |
---|---|---|---|---|---|
Net income 2024 * | -96M | Net income 2025 * | -123M | EV / Sales 2024 * | - |
Net cash position 2024 * | 43.16M | Net cash position 2025 * | 178M | EV / Sales 2025 * | -239 x |
P/E ratio 2024 * |
-1.31
x | P/E ratio 2025 * |
-1.22
x | Employees | 69 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.57% |
Latest transcript on Vigil Neuroscience, Inc.
1 day | -6.69% | ||
1 week | -9.25% | ||
Current month | -22.29% | ||
1 month | -11.67% | ||
3 months | -15.87% | ||
6 months | -67.24% | ||
Current year | -21.60% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | 20-06-30 | |
Director of Finance/CFO | 50 | 20-06-30 | |
Kelly Neelon
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | 20-06-30 | |
Mary Thistle
BRD | Director/Board Member | 64 | 22-04-17 |
Cheryl Blanchard
BRD | Director/Board Member | 59 | 20-10-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-22 | 2.84 | +0.71% | 40,601 |
24-04-19 | 2.82 | +2.55% | 64,624 |
24-04-18 | 2.75 | -5.82% | 50,239 |
24-04-17 | 2.92 | -3.63% | 42,887 |
24-04-16 | 3.03 | -4.11% | 60,572 |
Delayed Quote Nasdaq, April 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.60% | 107M | |
+3.13% | 42.11B | |
+48.83% | 40.08B | |
+8.49% | 40B | |
-10.82% | 26.87B | |
+8.26% | 24.58B | |
-23.69% | 18.44B | |
+1.58% | 11.94B | |
+32.83% | 11.66B | |
+6.63% | 11.01B |
- Stock Market
- Equities
- VIGL Stock